Serum levels of coenzyme Q10 in patients with Alzheimer's disease

Journal of Neural Transmission

Volumn 107, Issue 2, 2000, Pages 233-239

  De Bustos, F ^a   Molina, J A ^a   Jimenez Jimenez F J ^b,d   Garcia Redondo A ^a   Gomez Escalonilla C ^a   Porta Etessam, J ^a   Berbel, A ^a   Zurdo, M ^b   Barcenilla, B ^b   Parrilla, G ^e   Enriquez de Salamanca, R ^c   Arenas, J ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d C/ Corregidor Jose de Pasamonte   (Spain)

^e NONE

Author keywords

Alzheimer's disease; Coenzyme Q10; Dementia; Mitochondrial function; Oxidative stress; Serum levels; Vascular dementia

Indexed keywords

CHOLESTEROL; UBIDECARENONE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; MULTIINFARCT DEMENTIA; ONSET AGE; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0033981264     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050019     Document Type: Article

References (29)

1. American Psychiatric Association (1995) Diagnostic and statistical manual of mental disorders (DSM-IV). American Psychiatric Press, Washington DC
2. Benzi G, Moretti A (1995) Are reactive oxygen species involved in Alzheimer's disease? Neurobiol Aging 16: 661-674
3. Ernster L, Dallner G (1995) Biochemical, physiological and medical aspects of ubiquinone function. Ann Neurol 42: 261-264
4. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12: 189-198
5. Giubilei F, D'Antona R, Antonini R, Lenzi GL, Ricci G, Fieschi C (1990) Serum lipoprotein variations in dementia and ischemic stroke. Acta Neurol Scand 81: 84-86
6. Goate AM (1997) Molecular genetics of Alzheimer's disease. Geriatrics 52 [Suppl 2]: S9-12
7. Hachinski VC, Ihift LD, Zihka E, du Boulay GG, McAllister VL, Marshall J, Russell RW, Symon L (1975) Cerebral blood flow in dementia. Arch Neurol 32: 632-637
8. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62
9. Howland DS, Trusko SP, Savage MJ, Reaume AG, Lang DM, Hirsch JD, Maeda N, Siman R, Greenberg BD, Scott RW, Flood DG (1998) Modulation of sectreted beta-amyloid precursor protein and amylid beta-peptide in brain by cholesterol. J Biol Chem 273: 16576-16582
10. 6 in genetically-confirmed Alzheimer's disease. Lancet 340: 671
11. Jarvik GP, Wijsman EM, Kukull WA, Schellenberg GD, Yu C, Larson EB (1995) Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology 45: 1092-1096
12. Jiménez-Jiménez FJ, de Bustos F, Gasalla T, Ortí-Pareja M (1996) Estrés oxidativo y sistema nervioso central. In: Luquin MR, Jiménez-Jiménez FJ, Martínez-Vila E, Molina-Arjona JA, Bermejo-Pareja F, Coria-Balanzat F (eds) Mecanismos de muerte neuronal y neuroprotección en enfermedades neurológicas. Neurología 11 [Suppl 3]: 13-22
13. Jiménez-Jiménez FJ, Ortí-Pareja M, Molina JA (1998) Alteraciones mitocondriales en las enfermedades neurodegenerativas. In: Jiménez-Jiménez FJ, Molina JA, Arenas J (eds) Enfermedades mitocondriales. Rev Neurol 26 [Suppl 1]: S112-S117
14. Katzman R, Kawas C (1994) The epidemiology of dementia and Alzheimer's disease. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven Press, New York, pp 105-122
15. Kuusisto J, Koivisto K, Mykkanen L, Helkala EL, Vanhanen M, Hanninen T, Kervinen K, Kesaniemi YA, Riekkinen PJ, Laakso M (1997) Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional populacion based study. Br Med J 315: 1045-1049
16. 10 in human plasma as a possible marker of oxidative stress. J Lipid Res 37: 67-75
17. Lehtonen A, Luutonen S (1996) High density lipoprotein cholesterol levels of very old people in the diagnosis of dementia. Age Ageing 15: 367-270
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939-944
19. Mizuno T, Haass C, Michikawa M, Yanagisawa K (1998) Cholesterol-dependent generation of a unique amyloid beta-protein from apically missorted amyloid precursor protein in MDCK cells. Biochim Biophys Acta 1373: 119-130
20. Moreu E, Molinero LM, Fernández E (1990) R-Sigma: Base de datos bioestadística para un ordenador personal. Horus Hardware, Madrid
21. Mulder M, Ravid R, Swaab DF, de Kloet ER, Haasdijk ED, Julk J, Van der Bomm JJ, Havekes LM (1998) Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E. Alzheimer Dis Assoc Disord 12: 198-203
22. Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, Tuomilehto J, Nissinen A (1998) Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 17: 14-20
23. Ogasahara S, Engel AG, Frens D, Mack D (1989) Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci 86: 2379-2382
24. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, García JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43: 250-260
25. Schapira AHV (1994) Mitochondrial dysfunction in neurodegenerative disorders and aging. In: Schapira AHV, DiMauro S (eds) Mitochondrial disorders in neurology. Butterworth-Heinemann, Oxford, pp 227-244
26. 10 levels correlate with the activities of complexes I and II/III mitochondria from parkinsonian and nonparkinsonian patients. Ann Neurol 42: 261-264
27. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 95: 6460-6464
28. Soderberg M, Edlund C, Alafuzoff I, Kristensson K, Dallner G (1992) Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type. J Neurochem 59: 1646-1653
29. Sulkava R, Haltia M, Paetau A, Wikstrom J, Palo J (1983) Accuracy of clinical diagnosis in primary degenrative dementia: correlation with neuropathological findings. J Neurol Neurosurg Psychiatry 46: 9-13